sysa1801
cspc pharmaceuticals,elevation oncology
['sysa1801', 'cspc', 'eo-3021', 'cspc ', 'elevation oncology']
elevation oncology highlights first-in-human phase 1 sysa1801 (eo-3021) clinical data to be presented by partner cspc pharmaceutical group limited at asco 2023 
President of Russo Partners, a communications firm that works with innovators in healthcare and technology — and the home of the Sports-Health Alliance